(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2...eted by the ovary and is necessary for normal deve...ary sexual characteristics. It is also required fo...ch conducted has revealed that the hormone is very...act women with high levels of the sex hormone oe...
...sity of Iowa and colleagues at the Osmania Medical... Pedialyte are equally effective as oral rehydrati...elated to acute viral gastroenteritis.// The re...s at the 70th Annual Scientific Meeting of the Ame...
...Sleep Laboratory, Brown University has found a the...late. Study has found that teens are not intereste...y in the morning resulting in a reduction in sleep...work in the Journal American Academy of Sleep Medi...
...w cheek cell analysis which detects early lung can...sive and early screening method for detecting lung...sing buccal mucosa or cells scraped from the inner...that separates patients with lung cancer from high...
Other Medicine News:Health News:Early Lung cancer detected by studying Cheek Cells 2(Date:10/10/2008)...EEK, Mich., Oct. 10 /- Diplomat Speci...ce has selected Diplomat,Specialty Pharmacy to be ...scale, national Therapy Optimization Study for Mul...ear TOP MS study, is to examine the benefits of a,...ompliance, adherence and,patient outcomes. Targete...
(Date:10/10/2008)...Mass., Oct. 10 /- Inverness...g provider of near-patient,diagnostics, monitoring...th,Ban Ki-moon, the Secretary-General of the Unite... of seventeen of the world,s leading,research-base...ies.,Inverness, together with senior officials fro...
(Date:10/10/2008)...N, Calif., Oct. 10 /- TriReme Medical...rized to affix the CE (Conformite,Europeenne) mark...ronary,Stent System, a unique main vessel stent sy...y bifurcations., Representing the next generation...as potential use in a quarter of the 2.2 million,a...
(Date:10/9/2008)...ht Day 2008 focuses on the need to protect the eye...re/ -- Of the 45 million people worldwide who,are ...ers of them could,have avoided their blindness if ...view the Multimedia News Release, go to:, http://w...orld,s leader in eye care products and equipment, ...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Central DuPage Hospitals Orthopedics Ranks in U S News Media Groups 2008 Edition of Americas Best Hospitals for the Second Consecutive Year 23845 1Central DuPage Hospitals Orthopedics Ranks in U S News Media Groups 2008 Edition of Americas Best Hospitals for the Second Consecutive Year 23845 2Central DuPage Hospitals Orthopedics Ranks in U S News Media Groups 2008 Edition of Americas Best Hospitals for the Second Consecutive Year 23845 3Beta Blockers Help Hospitalized Heart Failure Patients 23838 1Beta Blockers Help Hospitalized Heart Failure Patients 23838 2Tennessee Seniors Medicare Advantage Benefits at Risk 23833 1Tennessee Seniors Medicare Advantage Benefits at Risk 23833 2Abuelos Responds to CDC and FDA Warning on Certain Types of Raw Peppers and Tomatoes 23831 1... , HORSOLM, Denmark, June 4, 2007-Professor Trond ...de vaccination in resected,pancreatic cancer patie... term survival" at ASCO,s (American Society of Cli...up study of 23 resected pancreatic cancer patients...o different,peptide vaccines targeting the RAS mut...
...cebo-controlled Trial,Ever Conducted in CTCL Prese... CHICAGO, June 04, 2007 /PRNewswire/ -- Preliminar...olled clinical trial ever,conducted in patients wi...TAK was more than twice as effective as placebo in...CL. [Abstract number 8026],The primary endpoint of...
Other Medicine Technology:Pharmexa A/S (DK) - Long lasting immune response and survival to,RAS vaccine 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 6...or active patients who want to take their aerosol ... is small and lightweight, yet powerful. Three ver...ity (100 to 240V), 12 volt DC and rechargeable bat...treatments away from home, in their car or around ...
Compact sporty design and powerful delivery make the CompAir XL the product of choice for those who demand affordability and performance. The CompAir XL features a sturdy handle, convenient cord stor
The 50 psi MaxiCompressor, the workhorse of compressors, is designed to run 24 hours a day, 7 days a week. It features a tamper-proof locking regulator valve to guard against unintentional increases
The TransNeb is a complete medication delivery system in a bag. The TransNeb is a compact, piston compressor providing high-performance while weighing only 11 oz. Versatility. Dependability. Simplici
Medicine Products: